Germany fears AstraZeneca vaccine won't get EU approval for those over 65 -Bild
- Country:
- Germany
AstraZeneca's COVID-19 vaccine is not very effective for people over 65, German coalition sources told tabloid Bild and Handelsblatt, a step which calls into question its suitability in mass vaccination programmes.
German officials fear that the AstraZeneca vaccine may not be approved by European Union authorities for use in those over 65, the German tabloid said in its online edition.
It marks another potential blow for AstraZeneca, which developed its shot with Oxford University. It told the EU on Friday it could not meet agreed supply targets up to the end of March.
ALSO READ
-
Belize Communities Take the Lead in New Push for Jobs, Skills and Stronger Futures
-
Hotter Years, More Cavities? Understanding Link Between Climate and Dental Health
-
Europe’s Rare Earth Wake-Up Call: Turning Years of Research Into Factories That Last
-
African Venture Capital Gets a Boost as Oxford Programme Builds Investor Connections
-
Lebanon’s Small Business Owners Build Skills and Market Links With EU and ILO Support
Google News